Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain
Patricia Montiel Villalonga(Organización Nacional de Trasplantes), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Mario Fernández‐Ruiz, Manuela Cid‐Cumplido(Hospital Universitario Virgen del Rocío), Elisabeth Coll(Organización Nacional de Trasplantes), Ibai Los‐Arcos(Vall d'Hebron Hospital Universitari), José Moya(Hospital Universitario Virgen de la Arrixaca), Itzíar Martínez‐Alpuente, G. Sánchez‐Etayo(Organización Nacional de Trasplantes), Marta Bodro(Hospital Clínic de Barcelona), Gabriel Moreno‐González(Bellvitge University Hospital), Ana Ávila(Hospital Universitario Doctor Peset), BRAULIO DE LA CALLE(Hospital General Universitario Gregorio Marañón), Óscar Len(Vall d'Hebron Hospital Universitari)
Cited by 10
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Donation after circulatory death today: an updated overview of the European landscape
|Transplant International|2019|317
COVID-19 pandemic and worldwide organ transplantation: a population-based study
|The Lancet Public Health|2021|312
Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation
|Journal of Hepatology|2018|291
Current situation of donation after circulatory death in European countries
|Transplant International|2011|285